Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04130503 · ClinicalTrials.gov registry record · NA

The Recovery in Stroke Using PAP Study

A NA study of Obstructive Sleep Apnea and Ischemic Stroke, sponsored by Yale University.

Recruiting
Registry status
NA
Development phase
360
Enrollment target
1
Study location

NCT04130503 is a NA study of Obstructive Sleep Apnea and Ischemic Stroke that is actively recruiting participants, run by Yale University. The registered enrollment target is 360 participants, above the 219-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (64% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04130503, a NA study of Obstructive Sleep Apnea and Ischemic Stroke, is actively recruiting participants, sponsored by Yale University.

RECRUITING
Registry status
NA
Development phase
360 participants
Enrollment target
1
Study location

Study Summary

The proposed study is a randomized controlled trial among an anicipated 180 participants with acute ischemic stroke and mod/severe OSA diagnosed by ambulatory polysomnography (PSG) comparing PAP treatment with usual care concerning the primary outcome of functional recovery.

Interventions

  • DEVICE PAP
  • BEHAVIORAL HLE

Study Locations (1)

Connecticut

  • Yale University - New Haven

Trial Details

FieldValue
Enrollment Target 360 participants
Start Date 2019-09-01
Est. Completion 2025-10
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT04130503

The ClinicalTrials.gov registry entry for NCT04130503 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 360 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 219-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (64% higher). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 2 interventions - of which PAP is the first listed.

NCT04130503 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT04130503 about?

NCT04130503 is a clinical study titled "The Recovery in Stroke Using PAP Study". The proposed study is a randomized controlled trial among an anicipated 180 participants with acute ischemic stroke and mod/severe OSA diagnosed by ambulatory polysomnography (PSG) comparing PAP treatment with usual care concerning the primary outcome of functional recovery.

What is the current status of trial NCT04130503?

This trial is currently recruiting. It is a NA study. The enrollment target is 360 participants. The study started on 2019-09-01. Estimated completion is 2025-10.

What conditions does trial NCT04130503 study?

This clinical trial studies the following conditions: Obstructive Sleep Apnea, Ischemic Stroke.

What interventions are being tested in trial NCT04130503?

The interventions under investigation include: PAP (DEVICE), HLE (BEHAVIORAL).

Who is sponsoring clinical trial NCT04130503?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04130503 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obstructive Sleep Apnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.